Phase I Open-Label, Dose-Escalation Study of GSK1059615 in Patients With Solid Tumors or Lymphoma
Clinical trial NCT00695448 · TERMINATED
Trial details
- NCT number
- NCT00695448
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-06-24
- Primary completion
- 2009-03-31
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.